Related Experiment Videos
Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects
Postgraduate Medical Journal
|April 1, 1981
Summary
Propranolol significantly reduced serum triiodothyronine (T3) levels in hyperthyroid patients, unlike other beta-blockers. All treatments offered symptomatic relief for hyperthyroidism.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Hyperthyroidism involves elevated thyroid hormone levels.
- Beta-adrenergic blocking agents are used to manage hyperthyroid symptoms.
Purpose of the Study:
- To investigate the effects of four beta-blockers on serum thyroid hormone concentrations in hyperthyroid patients.
- To compare the impact of atenolol, acebutolol, oxprenolol, and propranolol on thyroid hormone levels.
Main Methods:
- 24 hyperthyroid patients received daily treatment with atenolol, acebutolol, oxprenolol, or propranolol for 10 days.
- Serum thyroid hormone concentrations (including triiodothyronine) were measured pre-treatment and during treatment.
Main Results:
- Propranolol treatment led to a significant decrease in serum triiodothyronine (T3) concentrations (P < 0.05).
- Atenolol, acebutolol, and oxprenolol did not significantly alter serum thyroid hormone levels.
- All patients reported symptomatic improvement regardless of the specific beta-blocker used.
Conclusions:
- Propranolol exhibits a unique effect on serum T3 levels among the studied beta-blockers in hyperthyroidism.
- While beta-blockers alleviate symptoms, propranolol may also directly influence thyroid hormone metabolism.